Moreover, in xenograft mouse models, targeting USP22 has been shown to significantly inhibit the growth, angiogenesis and metastasis of NSCLC xenografts, as well as markedly extend the survival of mice bearing metastatic cancers [62]. The gene discussed is USP22; the disease is non-small cell lung carcinoma.